DSI inks pact with University of North Texas Health Science Center to offer PG ...pharmabiz.comSince India is gaining importance as a clinical research hub, there are scores of opportunities opening up. The trained professionals would be hired in as ...

Pique Therapeutics signs agreement with uk's Tecnomark Life SciencesBizjournals.comThe two companies will conduct Phase 2 clinical trials on Pique's product, called PT 107, which is aimed at the treatment of non-small cell lung cancer. ...NC-based Pique Therapeutics inks license agreement for lung cancer vaccineTechJournal Southall 3 news articles »

Phase Forward Inks Multi-Year Agreement with Major Eastern ...PharmaLive (press release) (subscription)Gedeon Richter plans to adopt Phase Forward's Clintrial™ product for its clinical trial data management activities. Founded in 1901 and headquartered in ...and more »

Biocon inks pact with Amylin to develop diabetes therapyBusiness StandardBiocon would utilise its expertise to manufacture the compound and also leverage its experience in pre-clinical and clinical development of diabetes ...Biocon, Amylin Pharma tie up to develop new diabetes drugMoneycontrol.comBiocon, US firm to jointly make drug for diabetesBombay NewsBiocon & Amylin Pharmaceuticals Join Hands For Anti-Diabetes Drugindia-server.comPharmaceutical Business Reviewall 56 news articles »

New Report Just Published: Global Botulinum ToxinBusiness Wire (press release)... Solstice Neurosciences Inks Licensing Agreement with DreamPharma II-38 Botox Enters India Market II-38 Mentor Begins Phase-I Clinical Trial on Botulinum ...and more »

Business StandardEli Lilly, Zydus Cadila enter drug development dealBusiness Standard, IndiaZydus will work to discover and develop potential molecules against a novel drug target, primarily in the area of cardiovascular research. This will include lead identification and optimization, pre-clinical trials and clinical trials up to second ...Cadila Health Signs Drug Devt Pact With Eli Lilly Wall Street JournalIndia Cadila and Eli Lilly in drug development deal ReutersZydus Cadila inks agreement with Eli Lilly for new drug discovery ... Equity BullsTrading Markets (press release)all 47 news articles

RTT NewsCadila Health Signs Drug Devt Pact With Eli LillyCNNMoney.comSuch a deal means that its multinational partner has faith and confidence in Cadila's drug discovery research operations," said Ranjit Kapadia, head of research for private client group at brokerage Prabhudas Lilladher. Last year, the mid-sized ...India Cadila and Eli Lilly in drug development deal ReutersZydus Cadila inks agreement with Eli Lilly for new drug discovery ... Equity Bullsall 21 news articles

Generex Biotechnology Inks Glucose RapidSpray Distribution Deal in ...MarketWatch - 7 hours ago... Type-1 and Type-2 diabetes and which was approved for sale in India in October 2007, is in Phase III clinical trials at several sites around the world. ...Generex Biotechnology Inks Glucose RapidSpray Distribution Deal in ... CNNMoney.com (press release)all 6 news articles

Itero Biopharmaceuticals Inks Partnership With Indian ...Business Wire (press release), CA - 1 hour ago... SVP and Chief Medical Officer, formerly SVP of Clinical Research and Medical Affairs at Scios, Inc. (J&J), Head of Cardiovascular Clinical Development ...

Eisai inks Japan's first major India data dealOutSourcing-Pharma.com, UK - 3 hours agoBy Kirsty Barnes 25-Feb-2008 - Japan's Eisai has inked a deal with Accenture to have it provide it with global clinical data management services from India, ...